13F-HR filed by First Turn Management, LLC
First Turn Management, LLC filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-08, with 31 holding rows worth $696,320,382.
- Accession
- 0001085146-24-000832
- Filer
- CIK 1993440
- Filed
- 2024-02-08
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2023
A holdings report, 31 entries on the cover page, a total value of $696,320,382 stated on the cover page (in dollars after the unit check, H1), rows summing to $696,320,382 with VALUE read as dollars as filed, 13F file number 028-23631. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CYTOKINETICS INC | 23282W605 | COM NEW | 807,444 | $67,413,500 | dollars as filed | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 1,497,331 | $35,366,958 | dollars as filed | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 81,683 | $33,235,996 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 83,403 | $31,729,003 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 680,389 | $31,338,717 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 242,185 | $30,045,471 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 476,079 | $28,645,673 | dollars as filed | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 87,369 | $27,653,162 | dollars as filed | |
| TRANSMEDICS GROUP INC | 89377M109 | COM | 323,185 | $25,508,992 | dollars as filed | |
| INSULET CORP COM | 45784P101 | Stock | 115,366 | $25,032,115 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 1,700,949 | $24,833,855 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 836,302 | $24,687,635 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 1,206,291 | $23,981,065 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 192,932 | $23,940,932 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 295,428 | $23,513,115 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 343,079 | $23,439,157 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 357,528 | $22,452,758 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 512,893 | $21,608,182 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 477,314 | $20,429,039 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 203,882 | $19,660,341 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 151,587 | $19,092,383 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 255,897 | $18,831,460 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 356,679 | $18,044,391 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 217,425 | $15,571,979 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 1,363,504 | $15,312,150 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 382,382 | $13,605,152 | dollars as filed | |
| SHOCKWAVE MED INC | 82489T104 | COM | 57,484 | $10,954,151 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 157,274 | $9,084,146 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 317,010 | $7,326,101 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 175,359 | $3,980,649 | dollars as filed | |
| SOMALOGIC INC | 83444k113 | WT | 17,953 | $2,154 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001085146-24-000832 | this filing | 2024-02-08 | acceptance time not in the bulk data set |